By: Ana Elcarte
Sanifit Enhances Leadership Team with New Executive Appointments
03/06/2020Palma, Spain and San Diego, USA, 01 June 2020 – Sanifit, a clinical-stage biopharmaceutical company focused on developing treatments for calcification... Read More
Vivet’s Product, VTX-803, receives US and EU Orphan Drug Designation
01/06/2020PARIS, France June 1st, 2020, Vivet Therapeutics announced today that both the Food and Drug Administration (FDA) and the European Commission... Read More
Viralgen will produce the COVID-19 vaccine developed in USA
29/05/2020AAVCOVID Vaccine Program Expands Manufacturing Agreements with Gene Therapy Industry Partners Viralgen, Aldevron, and Catalent The AAVCOVID vaccine program at Massachusetts... Read More
Artax Biopharma Appoints Joseph Lobacki as CEO
14/05/2020Autoimmune Disease Company Hires Life Science Industry Experts to Lead Company Through Next Stage into Human Clinical Studies with Novel Oral... Read More
The manufacturing challenge for AAV genetherapy
29/02/2020Editorial MedpageToday talks about Gene therapy and its challenges Read complete article here: https://www.medpagetoday.com/special-reports/exclusives/84956 Read More
Aura Biosciences presents updated clinical data for AU-011
25/02/2020Aura Biosciences presents updated phase 1b/2 clinical data for AU-011 at the 43rd Annual Macula Society Meeting Light-Activated AU-011 Holds Significant... Read More
Basque Country as the most attractive European region for foreign investment
24/02/2020The Financial Times ranks the Basque Country as the most attractive mid-sized European region for foreign direct investment strategy For the... Read More
Valuable in-kind donation from Viralgen for Gene Therapy research
20/02/2020Viralgen Vector Core, the leading GMP manufacturer of adeno associated virus, has recently donated a large in kind donation to Columbus... Read More
Quirónsalud treats the first patient with protontherapy in Spain
19/02/2020Quirónsalud treated the first patient in Spain with proton therapy at his Proton Therapy Center in Madrid https://www.quironsalud.es/es/comunicacion/notas-prensa/quironsalud-trata-primer-paciente-espana-terapia-protones Read More
First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis
13/02/2020First patient dosed in phase 3 trial of SNF472 for the treatment of calcific uremic arteriolopathy (CUA) or calciphylaxis Palma,... Read More